Fundraising Fox
/People
Sign in

Scott Biller

Investor

Executive Venture Partner at GV (Google Ventures) · Director at Remix Therapeutics

Boston, Massachusetts

Writes $250K – $50M checks · typically $25M

Find your path to Scott

244 people in our graph can introduce you to Scott.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Pat Sharp to introduce you to Scott

You →Pat · together at Gate Bioscience (2021–2026) →Scott

Ask Jamie Chen to introduce you to Scott

You →Jamie · 4 people · together at ROME Therapeutics →Scott

Ask Sam Okafor to introduce you to Scott

You →Sam · together at Denali Therapeutics →Scott

Sign up to find every way you can get introduced to Scott

  • Your email: the people you already email who know Scott
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Scott
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Dr. Scott Biller is an Executive Venture Partner at GV with a deep R&D background, having served as Chief Scientific Officer of Agios Pharmaceuticals and held leadership roles at Novartis and Bristol-Myers Squibb. He advises and sits on the boards of several biotech companies including Foghorn, Remix, Rome, and OMass Therapeutics.

Invests in

BiotechMedical Devices

Director at Remix Therapeutics

Intro paths

→

In turn, Scott can intro founders to Remix Therapeutics's investors below.

Remix Therapeutics's investors · 5

ARCH Venture PartnersChicago · $50K – $250M checks · since 2023Atlas VentureCambridge · $500K – $1M checks · since 2024Decheng CapitalMenlo Park · since 2023Foresite CapitalWest Hollywood · since 2024The Column GroupSan Francisco · $30M checks · since 2024

Co-founders at Remix Therapeutics

PS
Peter Smith, PhDCo-Founder, President and Chief Executive Officer
PS
Peter SmithCo-Founder, President and Chief Executive Officer

Experience

  1. OMass TherapeuticsBoard Membercurrent2022 — present
  2. GVExecutive Venture Partnercurrent2021 — presentCambridge, Massachusetts, United States
  3. ROME TherapeuticsBoard Membercurrent2021 — present
  4. Gate BioscienceBoard Observercurrent2021 — present
  5. Remix TherapeuticsBoard Membercurrent2020 — present
  6. Foghorn Therapeutics, IncBoard Membercurrent2020 — present
  7. VividionScientific Advisory Board member2019 — 2024
  8. Agios PharmaceuticalsScientific Advisory Board member2021 — 2023
  9. Agios PharmaceuticalsStrategic Advisor2020 — 2021
  10. Agios PharmaceuticalsChief Scientific Officer2010 — 2019
  11. Denali TherapeuticsScientific Advisory Board member2015 — 2023
  12. Novartis Institutes for BioMedical ResearchVice President, Global Discovery Chemistry2003 — 2010
  13. Bristol-Myers SquibbVice President, Pharmaceutical Candidate Optimization2001 — 2003
  14. Bristol Myers SquibbDirector, Executive Director, Discovery Chemistry1995 — 2001
  15. MITStudent1972 — 1976

Skills & more

Drug DiscoveryMedicinal Chemistry56Pharmaceutical Industry82Drug Design40Organic Chemistry52Oncology34ChemistryDrug DevelopmentLead Change24Lifesciences16Pharmacology27Cancer12
+7 moreBiochemistryADMEAssay DevelopmentCRONeuroscienceOrganic SynthesisLife Sciences

From Scott's professional profile.

Investments

Board seats

Foghorn TherapeuticsOMASS TherapeuticsRemix TherapeuticsRome Therapeutics

Sources: the firm's website · curated public sources.

Colleagues at GV (Google Ventures)

Abi Joyce
Executive Business Partner at GV (Google Ventures)
Amy Anton
Talent Partner at GV (Google Ventures)
Anika Gupta
Investor at GV (Google Ventures)
Anthony Philippakis
Investor at GV (Google Ventures)
Araceli Pacheco
Sr. Financial Analyst at GV (Google Ventures)
Ben Robbins
Investor at GV (Google Ventures)
Brendan Bulik-Sullivan
Investor at GV (Google Ventures)
Caleb Langlinais
Financial Analyst at GV (Google Ventures)

Frequently asked questions

Who is Scott Biller?
Dr. Scott Biller is an Executive Venture Partner at GV with a deep R&D background, having served as Chief Scientific Officer of Agios Pharmaceuticals and held leadership roles at Novartis and Bristol-Myers Squibb. He advises and sits on the boards of several biotech companies including Foghorn, Remix, Rome, and OMass Therapeutics.
Where does Scott Biller work?
Scott Biller is Executive Venture Partner at GV (Google Ventures).
What does Scott Biller invest in?
Scott Biller invests in Biotech, Medical Devices.
What check size does Scott Biller write?
Scott Biller typically writes checks of $250K – $50M.
What boards does Scott Biller sit on?
Scott Biller holds tracked board seats at Foghorn Therapeutics, OMASS Therapeutics, Remix Therapeutics, Rome Therapeutics.
What companies has Scott Biller invested in?
Investments tracked here include Gate Bio, Omass.
Where did Scott Biller go to school?
Scott Biller studied at Massachusetts Institute of Technology (BS, Chemistry); Columbia University (Postdoc, Organic Chemistry); Caltech (PhD, Organic Chemistry).

Same school

Shared employers